Goldman Sachs’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Goldman Sachs’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-35,700	Closed	-$1.02M	–	7683
2015 Q2	$1.02M	Sell	35,700 -16,900	-32%	-$492K	﹤0.01%	4529
2015 Q1	$1.44M	Buy	+52,600	New	+$1.45M	﹤0.01%	4112
2014 Q4	–	Sell	-25,000	Closed	-$754K	–	7485
2014 Q3	$754K	Buy	+25,000	New	+$774K	﹤0.01%	4902
2014 Q2	–	Sell	-55,000	Closed	-$1.78M	–	7273
2014 Q1	$1.78M	Sell	55,000 -245,000	-82%	-$8.58M	﹤0.01%	4089
2013 Q4	$10.9M	Sell	300,000 -175,000	-37%	-$6.8M	﹤0.01%	2299
2013 Q3	$18.5M	Buy	+475,000	New	+$19.1M	0.01%	1687

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Goldman Sachs's MR Position: Q1 2016 in Review

Goldman Sachs sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 291,047 shares — an estimated $7.89M sold.

Goldman Sachs first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $8.01M in Q4 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

Goldman Sachs reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
Goldman Sachs sold 291,047 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $7.89M.
Goldman Sachs first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
Goldman Sachs's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $8.01M in Q4 2013.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.